Single Mutation in the Linker Domain Confers Protein Flexibility and Camptothecin Resistance to Human Topoisomerase I
Open Access
- 1 October 2003
- journal article
- Published by Elsevier
- Vol. 278 (44) , 43268-43275
- https://doi.org/10.1074/jbc.m303899200
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- The mechanism of topoisomerase I poisoning by a camptothecin analogProceedings of the National Academy of Sciences, 2002
- Domain Interactions Affecting Human DNA Topoisomerase I Catalysis and Camptothecin SensitivityMolecular Pharmacology, 1999
- A Functional Linker in Human Topoisomerase I Is Required for Maximum Sensitivity to Camptothecin in a DNA Relaxation AssayPublished by Elsevier ,1999
- Investigating the biological functions of DNA topoisomerases in eukaryotic cellsBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1998
- Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzymeBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1998
- Crystal Structures of Human Topoisomerase I in Covalent and Noncovalent Complexes with DNAScience, 1998
- A Model for the Mechanism of Human Topoisomerase IScience, 1998
- DNA TOPOISOMERASESAnnual Review of Biochemistry, 1996
- DNA Topoisomerases: Essential Enzymes and Lethal TargetsAnnual Review of Pharmacology and Toxicology, 1994
- Detection of topoisomerase I gene point mutation in CPT-11 resistant lung cancer cell lineBiochemical and Biophysical Research Communications, 1992